L1-Specific Protection from Tumor Challenge Elicited by HPV16 Virus-like Particles
Marloes L. H. De Bruijn(National Institutes of Health), W. Martin Kast(University of Southern California), Heather L. Greenstone(National Institutes of Health), Cornelis J.M. Melief(Leiden University), Hans Vermeulen(Leiden University), Douglas R. Lowy(National Cancer Institute), John T. Schiller(National Cancer Institute)
Cited by 69
Related Papers
Toward a Shared Vision for Cancer Genomic Data
|New England Journal of Medicine|2016|1.8k
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
|Nature Medicine|1995|1.1k
HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes.
|The EMBO Journal|1989|930
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
|The Journal of Immunology|1994|851
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
|European Journal of Immunology|1993|840